About 100 reports

Types of Monoclonal Antibodies Table ##. ##.

  • Cancer Immunotherapy
  • Therapy
  • World
  • Market Size
  • IV. KIDNEY CANCER TREATMENT DRUGS PRODUCTION AND

The total sales volume of monoclonal antibody reached ## million Yuan in 2018.

  • Cancer Immunotherapy
  • China
  • Demand
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd

Types of Monoclonal Antibodies Table ##. ##.

  • Cancer Immunotherapy
  • Therapy
  • World
  • Market Size

The market for monoclonal antibodies dominates the market in terms of revenue.

  • Cancer Immunotherapy
  • Therapy
  • World
  • Market Size

Monoclonal Antibodies ##. ##.

  • Cancer Immunotherapy
  • Therapy
  • World
  • Market Size

Based on technology, the market is segmented into Monoclonal Antibodies, Cytokines & Immunomodulators and other technology.

  • Cancer Immunotherapy
  • Therapy
  • North America
  • United States
  • Market Size

Some are in the pipeline and are being tested for their ability to provide better cancer treatment Further Key Findings From the Report Suggest: • Monoclonal antibodies emerged as the largest segment in 2017 because of increasing regulatory approvals and higher efficacy • Target id

  • Cancer Immunotherapy
  • Therapy
  • United States
  • Forecast
  • GLOBAL CANCER IMMUNOTHERAPIES MARKET BY TYPE OF CANCER IMMUNOTHERAPIES 2015
  • HIGHLIGHTS

Cancer monoclonal antibodies that target either PD-## or PD-L## quicken the immune response against cancer cells, thereby showing efficacy in treating cancer.

  • Cancer Immunotherapy
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • F. Hoffmann-La Roche Ltd.
  • Merck & Co., Inc.

New Era of Monoclonal Antibodies ##. ## Rudiments of Monoclonal Antibodies ##. ## Advents of Monoclonal Antibodies ##. ## Commercial Aspects of Monoclonal Antibodies ##.

  • Cancer Immunotherapy
  • Medical Biotechnology
  • Therapy
  • World

Based on technology, the market is segmented into Monoclonal Antibodies, Cytokines & Immunomodulators and other technology.

  • Cancer Immunotherapy
  • Therapy
  • North America
  • United States
  • Market Size

Based on technology, the market is segmented into Monoclonal Antibodies, Cytokines & Immunomodulators and other technology.

  • Cancer Immunotherapy
  • Therapy
  • Europe
  • United States
  • Market Size

Based on technology, the market is segmented into Monoclonal Antibodies, Cytokines & Immunomodulators and other technology.

  • Cancer Immunotherapy
  • Oncology
  • Therapy
  • United States
  • Market Size

Based on technology, the market is segmented into Monoclonal Antibodies, Cytokines & Immunomodulators and other technology.

  • Cancer Immunotherapy
  • Therapy
  • APAC
  • United States
  • Market Size

Assessment of Dendritic Vaccines with Other Therapeutic Regimens ##. ## Dendritic Cell Cancer Vaccine & Monoclonal Antibodies ##. ## Dendritic Cell Cancer Vaccine & Peptide Based Cancer Vaccine ##. ## Dendritic Cell Cancer Vaccine & Cytokine Based Cancer Vaccine ##. ## Dendritic Ce

  • Cancer Immunotherapy
  • Cell Therapy
  • Medical Biotechnology
  • Therapy
  • World

MONOCLONAL ANTIBODIES ##. ##. ##.

  • Cancer Immunotherapy
  • Therapy
  • World
  • Market Size

Dendritic Cell Cancer Vaccine Combination Therapy with other Cancer Therapies ##. ## Dendritic Cell Cancer Vaccine with Radiotherapy ##. ## Dendritic Cell Cancer Vaccine with Monoclonal Antibodies ##.

  • Cancer Immunotherapy
  • Cell Therapy
  • Medical Biotechnology
  • Therapy
  • World

Tysabri is a recombinant humanized immunoglobulin (IgG##) monoclonal antibody (mAb).

  • Cancer Immunotherapy
  • Biogen Idec Inc.
  • Novartis AG
  • Roche Group
  • Sanofi S.A.

Monoclonal Antibodies ##. ##. ##.

  • Cancer Immunotherapy
  • Therapy
  • APAC
  • World
  • Market Size

Based on Technology, the market report segments the market into Monoclonal Antibodies, Cytokines & Immunomodulators, and Other Technology.

  • Cancer Immunotherapy
  • Oncology
  • Therapy
  • United States
  • Market Size
  • LEADING TREATMENTS FOR HNCS
  • KEYTRUDA SWOT ANALYSIS

AZ' S IMFINI IS A HUMANIZED MONOCLONAL ANTIBODY AGAINST PD-L##.

  • Cancer
  • Cancer Immunotherapy
  • Chemotherapy
  • Hospital
  • Therapy

It offers antibodies such as monoclonal antibody hu##s## - anti-ley, monoclonal antibody ##-## - anti-leb, monoclonal antibody mx##, and monoclonal antibody a##.

  • Cancer
  • Cancer Immunotherapy
  • Immunotherapy
  • Specialty Hospital
  • Therapy
  • Product offerings in global autoimmune and inflammatory immunomodulators market

April 2015: WuXi receives China FDA approval for an investigational new drug application for its anti-IL## monoclonal antibody for rheumatoid arthritis.

  • Cancer Immunotherapy
  • Therapy
  • AbbVie Inc.
  • Amgen Inc.
  • F. Hoffmann-La Roche Ltd.

This substance may be bound to a pharmaceutical compound such as a monoclonal Antibody (mAb) in order to selectively target malignant cells (NCI, 2010).

  • Cancer Immunotherapy
  • Market Size
  • Juno Therapeutics Inc.
  • Merck & Co., Inc.
  • Novartis AG
  • 4.4.1.3 Molecular Target
  • 4.4.3.3 Molecular Target

Antibody blockade of PD-## has showed promise in the treatment of several malignancies.

  • Cancer Immunotherapy
  • Therapy
  • Urology
  • Astellas Pharma Inc.
  • Pfizer Inc.

Ongoing Major product classes include monoclonal antibodies, therapeutic vaccines, and immune checkpoint inhibitors.

  • Cancer Immunotherapy
  • Foundation Medicine, Inc.
  • GE Healthcare Limited
  • General Electric Company
  • NVIDIA Corporation
  • Source: GBI Research Proprietary Pipeline Product Database, GBI Research Analysis
  • Source: GBI Research Proprietary Deals Database, GBI Research Analysis

Safety, Activity, and Immune Correlates of Anti-PD-## Antibody in Cancer.

  • Cancer Immunotherapy
  • Market Size
  • Bristol-Myers Squibb Company
  • Celgene Corporation
  • Merck & Co., Inc.

The consistent number of product approvals of highly significant monoclonal antibodies in autoimmune diseases is predicted to be responsible for widening the scope of growth.

  • Cancer Immunotherapy
  • Therapy
  • United States
  • Forecast
  • BRISTOL-MYERS SQUIBB - 2/2
  • AGENUS - 1/2

Precl Xencor Antibody ## ## PD-## x LAG- ## Antibody PD-## and LAG-## Multiple oncology indications Rec bispecific monoclonal antibody with engineered Fc (Xencor' s XTend technology) LAG-## Antagonists - ##/ ## ## ## LAG-## x PD- L## Bi

  • Cancer Immunotherapy
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • Incyte Corporation
  • Medarex, Inc.

There are several combinational therapies wherein dendritic cells are administered along with monoclonal antibodies, antibody-drug conjugates and peptide based vaccines to increase the efficacy of the vaccines.

  • Biopharmaceutical
  • Cancer Immunotherapy
  • Cell Therapy
  • Medical Biotechnology
  • Therapy
  • 7. Global Cancer Vaccines Market - Major Deals

Durvalumab is a monoclonal antibody directed against programmed cell death ligand ## (PD-L##).

  • Cancer Immunotherapy
  • World
  • Altor BioScience Corporation
  • GlobeImmune, Inc.
  • Merck & Co., Inc.